June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
CRB-1 rd8 Mutation Influences the Extent of AMD-like Retinal Alterations in NRF2 Knock Out Mice and Favors CNV Formation
Author Affiliations & Notes
  • Jan Tode
    Ophthalmology, Christian-Albrechts-University Kiel, Kiel, Germany
  • Elisabeth Richert
    Ophthalmology, Christian-Albrechts-University Kiel, Kiel, Germany
  • Alexa Klettner
    Ophthalmology, Christian-Albrechts-University Kiel, Kiel, Germany
  • Claus Christian von der Burchard
    Ophthalmology, Christian-Albrechts-University Kiel, Kiel, Germany
  • Stefan Otto Johannes Koinzer
    Ophthalmology, Christian-Albrechts-University Kiel, Kiel, Germany
  • Johann Roider
    Ophthalmology, Christian-Albrechts-University Kiel, Kiel, Germany
  • Footnotes
    Commercial Relationships   Jan Tode, None; Elisabeth Richert, None; Alexa Klettner, None; Claus von der Burchard, None; Stefan Koinzer, None; Johann Roider, None
  • Footnotes
    Support  BMBF grant 13GW0043D
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 1989. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jan Tode, Elisabeth Richert, Alexa Klettner, Claus Christian von der Burchard, Stefan Otto Johannes Koinzer, Johann Roider; CRB-1 rd8 Mutation Influences the Extent of AMD-like Retinal Alterations in NRF2 Knock Out Mice and Favors CNV Formation
      . Invest. Ophthalmol. Vis. Sci. 2017;58(8):1989.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinal degeneration (rd)8 mutation of the human crumbs homolog (CRB)-1 gene is known to lead to neuroretinal degeneration. Rd8 mutation may confound retinal alterations in age related macular degeneration (AMD) mouse models with implications for AMD research. We tested the influence of the rd8 mutation on AMD-like alterations in the nuclear factor E2-related factor 2 knock out (NRF2-/-) AMD mouse model.

Methods : CRB-1 rd8 mutation genotype was determined by PCR from tail clips in 73 NRF2-/- mice originating from a C57BL/6J background purchased from Jackson Labs (Bar Harbor, ME USA). All mice were examined by funduscopy and optical coherence tomography (OCT) at the age of 9 or 12 months to evaluate the clinical score of AMD-like retinal alterations. Clinical score was determined by the number of drusen (1= physiological retina, 2= 1-14 drusen, 3= 15-100 drusen, 4= >100 drusen, 5= any number of drusen + choroidal neovascularization [CNV], retinal pigment epithelium (RPE)/retinal atrophy or hemorrhage) in a standardized manner. CNV was confirmed by fluorescein angiography (FLA).

Results : Twelve NRF2-/- mice were heterozygote for CRB-1 rd8 mutation, 61 were homozygote. Drusen could be seen by funduscopy in most eyes and verified by OCT. Seventeen % (4/24 eyes) of the heterozygote mice had a physiological retina, 3 % (4/122 eyes) of the homozygote mice. Forty six % (11/24 eyes) of the heterozygote mice had grade 2 AMD-like alterations vs. 29 % (35/122) of the homozygote. Twelve % (3/24 eyes) of the heterozygote mice had grade 4 AMD-like fundus alterations vs. 36 % (44/122 eyes) of the homozygote mice. No CNV was detected in heterozygote mice, but in 16 eyes of the homozygote, thus significant, CNV was detected and confirmed by OCT and FLA. The pattern of drusen distribution across the retina did not follow a certain scheme, it was homogenous. There was no significant difference in AMD score concerning age (9 or 12 months).

Conclusions : Homozygote CRB-1 rd8 mutation can be found in a commercial vendor mice strain of C57BL/6J origin. The mutation has an influence on the extent of AMD-like retinal alterations in NRF2-/- mice. However, these alterations may develop independently of rd8 mutation. CRB-1 rd8 mutation may favor CNV formation.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×